Blue Fin Capital Upped Apple Com (AAPL) Holding By $11.85 Million; INTERLEUKIN GENETICS (ILIU) Shorts Up By 411.49%

October 21, 2017 - By Nellie Frank

Blue Fin Capital Inc increased Apple Inc Com (AAPL) stake by 839.56% reported in 2017Q2 SEC filing. Blue Fin Capital Inc acquired 82,277 shares as Apple Inc Com (AAPL)’s stock rose 12.78%. The Blue Fin Capital Inc holds 92,077 shares with $13.26 million value, up from 9,800 last quarter. Apple Inc Com now has $807.07B valuation. The stock increased 0.17% or $0.27 on October 20, reaching $156.25. About 23.97M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since October 21, 2016 and is uptrending. It has outperformed by 45.78% the S&P500.

INTERLEUKIN GENETICS (OTCMKTS:ILIU) had an increase of 411.49% in short interest. ILIU’s SI was 253,700 shares in October as released by FINRA. Its up 411.49% from 49,600 shares previously. With 166,600 avg volume, 2 days are for INTERLEUKIN GENETICS (OTCMKTS:ILIU)’s short sellers to cover ILIU’s short positions. It closed at $0.009 lastly. It is down 0.00% since October 21, 2016 and is . It has underperformed by 16.70% the S&P500.

Interleukin Genetics, Inc. develops and markets genetic tests for chronic diseases and health-related conditions. The company has market cap of $2.07 million. The Firm operates through the genetic test business segment. It currently has negative earnings. The Company’s products include PerioPredict genetic test and Inherent Health line of genetic tests.

Investors sentiment increased to 0.68 in Q2 2017. Its up 0.04, from 0.64 in 2017Q1. It improved, as 62 investors sold AAPL shares while 1068 reduced holdings. 129 funds opened positions while 634 raised stakes. 3.06 billion shares or 2.38% less from 3.13 billion shares in 2017Q1 were reported. Verity Asset Mgmt Inc has 0.61% invested in Apple Inc. (NASDAQ:AAPL). Burt Wealth holds 0.94% or 9,468 shares. Legal & General Grp Inc Public Ltd Company has 26.11 million shares. 778,466 are held by Sawgrass Asset Management Ltd Co. Moreover, Lpl Fin has 0.94% invested in Apple Inc. (NASDAQ:AAPL). Rosenbaum Jay D reported 4.24% of its portfolio in Apple Inc. (NASDAQ:AAPL). Wasatch Advsr reported 67,667 shares. Sta Wealth Mgmt Ltd Liability Corp has 0.36% invested in Apple Inc. (NASDAQ:AAPL). Levy Harkins And Communication has 169,155 shares for 8.5% of their portfolio. Broderick Brian C accumulated 56,225 shares. Fenimore Asset Inc accumulated 1,414 shares or 0.01% of the stock. Massachusetts-based Essex Mngmt Co Ltd Limited Liability Company has invested 2.89% in Apple Inc. (NASDAQ:AAPL). Harvey holds 101,973 shares or 6.3% of its portfolio. Mountain Pacific Investment Advisers Id holds 6,491 shares. Jarislowsky Fraser Limited holds 0.02% or 18,397 shares in its portfolio.

Since May 4, 2017, it had 0 insider buys, and 11 insider sales for $54.79 million activity. Riccio Daniel J. sold $1.86M worth of stock or 11,949 shares. Maestri Luca had sold 4,757 shares worth $735,898 on Friday, June 2. $1.53 million worth of Apple Inc. (NASDAQ:AAPL) shares were sold by Srouji Johny. Shares for $3.91 million were sold by AHRENDTS ANGELA J on Tuesday, May 9. Shares for $10.04M were sold by SEWELL D BRUCE. $5.39M worth of Apple Inc. (NASDAQ:AAPL) was sold by LEVINSON ARTHUR D on Tuesday, May 9. Another trade for 64,500 shares valued at $9.91 million was made by FEDERIGHI CRAIG on Tuesday, May 23.

Among 47 analysts covering Apple Inc. (NASDAQ:AAPL), 37 have Buy rating, 1 Sell and 9 Hold. Therefore 79% are positive. Apple Inc. had 307 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, August 24 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, August 2 by Robert W. Baird. The rating was maintained by Pacific Crest with “Overweight” on Monday, March 7. The stock has “Buy” rating by Maxim Group on Tuesday, January 31. JP Morgan maintained Apple Inc. (NASDAQ:AAPL) on Friday, September 11 with “Buy” rating. On Tuesday, August 1 the stock rating was maintained by Oppenheimer with “Hold”. The firm earned “Perform” rating on Wednesday, April 27 by Oppenheimer. The rating was maintained by Needham with “Buy” on Wednesday, August 2. The stock has “Outperform” rating by Oppenheimer on Friday, September 11. The firm has “Buy” rating given on Wednesday, October 26 by Citigroup.